Montero, Joan
Barcelona Institute of Science and Technology · Institute for Bioengineering of Catalonia
8 papers on CoChatORCID 0000-0002-9192-4836
Most cited papers
- Verified
Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy
Montero, J., Sarosiek, K. A., DeAngelo, J. D., Maertens, O., Ryan, J., Ercan, D., Piao, H., Horowitz, N. S., Berkowitz, R. S., Matulonis, U., et al. (2015) · Cell
Cell death mechanisms and regulationCancer-related Molecular Pathways
Cited by 378
- Verified
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
Townsend, E. C., Murakami, M. A., Christodoulou, A., Christie, A. L., Köster, J., DeSouza, T. A., Morgan, E. A., Kallgren, S. P., Liu, H., Wu, S.-C., et al. (2016) · Cancer Cell
Acute Lymphoblastic Leukemia researchAcute Myeloid Leukemia Research
Cited by 295
- Verified
Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors.
Ercan, D., Xu, C., Yanagita, M., Monast, C. S., Pratilas, C. A., Montero, J., Butaney, M., Shimamura, T., Sholl, L., Ivanova, E. V., et al. (2012) · Cancer Discovery
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 294
- Verified
Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis
Lagares, D., Santos, A., Grasberger, P. E., Liu, F., Probst, C. K., Rahimi, R. A., Sakai, N., Kuehl, T., Ryan, J., Bhola, P., et al. (2017) · Science Translational Medicine
Systemic Sclerosis and Related DiseasesCell death mechanisms and regulation
Cited by 246
- Verified
The public repository of xenografts enables discovery and randomized phase II-like trials in mice
Townsend, E. C., Murakami, M. A., Christodoulou, A., Christie, A. L., Köster, J., DeSouza, T. A., Morgan, E. A., Kallgren, S. P., Liu, H., Wu, S.-C., et al. (2016) · Cancer Cell
Acute Lymphoblastic Leukemia researchAcute Myeloid Leukemia Research
Cited by 80
- Verified
Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian Cancer
Stover, E. H., Baco, M. B., Cohen, O., Li, Y. Y., Christie, E. L., Bagul, M., Goodale, A., Lee, Y., Pantel, S., Rees, M. G., et al. (2019) · Molecular Cancer Research
Cell death mechanisms and regulationOvarian cancer diagnosis and treatment
Cited by 49
- Verified
PI3Kδ inhibition reshapes follicular lymphoma–immune microenvironment cross talk and unleashes the activity of venetoclax
Serrat, N., Guerrero-Hernández, M., Matas-Céspedes, A., Yahiaoui, A., Valero, J. G., Nadeu, F., Clot, G., Di Re, M., Corbera-Bellalta, M., Magnano, L., et al. (2020) · Blood Advances
Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research
Cited by 32
- Verified
The MDM2 Inhibitor NVP-CGM097 Is Highly Active in a Randomized Preclinical Trial of B-Cell Acute Lymphoblastic Leukemia Patient Derived Xenografts
Townsend, E. C., DeSouza, T., Murakami, M. A., Montero, J., Stevenson, K., Christie, A. L., Christodolou, A. N., Vojinovic, U., Kopp, N., Barzaghi-Rinaudo, P., et al. (2015) · Blood
Acute Lymphoblastic Leukemia researchCancer-related Molecular Pathways
Cited by 10
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free